Shares of Lam Research surged nearly +15% on Thursday, after the company reported an estimate-beating Q2 performance.
According to the company, 2018 proved to be the strongest financial year in its history, after it reported +14%, +27% and +50% growth in revenue, EPS and operating cash flow, respectively.
For the second quarter, the company reported revenue of $2.55 billion compared to analyst estimates of $2.45 billion, and reported an EPS of $3.87 against an estimate of $3.38.
A gross margin of 46.3% also beat consensus by 0.3%, while operating margin stood at 28.8% against a consensus of 27.5%. Ending deferred revenue for the company for Q2 stood at $493 million compared to the $626 million in Q1.
Lam Research has also confirmed a $5 billion share repurchase program that will be carried out through combination of cash on hand, cash generation, and borrowings. According to analysts, this underscores the faith the company has in its long-term strategies.
The 50-day moving average for LRCX moved above the 200-day moving average on June 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on LRCX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for LRCX just turned positive on June 09, 2025. Looking at past instances where LRCX's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LRCX advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 261 cases where LRCX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LRCX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
LRCX broke above its upper Bollinger Band on June 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LRCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.649) is normal, around the industry mean (9.257). P/E Ratio (37.872) is within average values for comparable stocks, (63.080). Projected Growth (PEG Ratio) (2.793) is also within normal values, averaging (2.334). Dividend Yield (0.008) settles around the average of (0.020) among similar stocks. P/S Ratio (9.174) is also within normal values, averaging (33.448).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of semiconductor processing equipment
Industry Semiconductors